Indonesian vape associations demand data on health risk claims

Three Indonesian vape industry associations—the Indonesian Personal Vaporizer Association (APVI), the Indonesian E-liquid Producers Association (PPEI), and the Indonesian Vape Retail Association (Arvindo)—are demanding that the National Research and Innovation Agency (BRIN) release the data and methodology behind recent claims linking e-cigarettes to health risks.

The controversy stems from findings suggesting that vaping could lead to a 100 percent increased risk of diabetes and a 92 percent increased risk of lung disorders. Industry representatives have questioned the parameters and testing methods used, noting that a 2025 BRIN study previously indicated that toxin levels in vape products were lower than those in conventional cigarettes.

Industry leaders stated they are not dismissing health risks but require full transparency regarding research context, samples, and indicators. They emphasized that the sector is a labor-intensive industry involving many local players. The associations expressed readiness to evaluate new evidence and improve products if scientific findings are substantiated, while also planning independent health screenings for users.